Understand the source comparison
Best Peptides for Joint Health: Mechanism Comparison
BPC-157 VEGF upregulation → angiogenesis at injury sites; promotes fibroblast migration and collagen synthesis Subcutaneous injection (daily) 200–500mcg/day for 4–8 weeks Symptomatic pain reduction: 7–14 days; structural healing markers: 4–6 weeks Best evidenc
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF upregulation → angiogenesis at injury sites; promotes fibroblast migration and collagen synthesis
- Subcutaneous injection (daily)
- 200–500mcg/day for 4–8 weeks
- Symptomatic pain reduction: 7–14 days; structural healing markers: 4–6 weeks
- Best evidence for acute injury repair and tendon-to-bone healing; requires consistent daily dosing and proper reconstitution to maintain efficacy
- TB-500
- Downregulates TNF-alpha/IL-6; promotes actin polymerization and cellular migration to injury sites
- Subcutaneous or intramuscular injection (twice weekly loading, weekly maintenance)
- Loading: 2–5mg twice/week × 4 weeks; Maintenance: 2mg weekly
- Inflammation reduction: 10–14 days; functional improvement: 6–8 weeks
- Strongest immune modulation profile; effective for chronic inflammatory joint conditions; less frequent dosing increases compliance
- Collagen Peptides (Type II)
- Provides hydroxyproline and glycine for cartilage ECM synthesis; stimulates chondrocyte activity
- Oral (daily)
- 10–15g/day continuously
- Cartilage thickness changes: 12–16 weeks; pain reduction: 8–12 weeks
- Only orally bioavailable option; requires higher absolute doses and longer timelines; best for cartilage-specific degeneration rather than ligament/tendon injuries